Updates on Mitochondrial Myopathies
Emanuele Barca1, Valentina Emmanuele2
1Department of Neurology, Columbia University Medical Center, New York, USA. eb2877@cumc.columbia.edu.
Purpose Of Review:
Mitochondrial myopathies (MM) are a genetically and clinically heterogeneous group of disorders that remain underrecognized in adult and pediatric neurology. This review aims to provide a clinically useful tool for guiding diagnosis and management of MM. We also highlight the rapidly evolving diagnostic and therapeutic landscape, including novel diagnostic approaches and disease-modifying interventions.
Recent Findings:
Large cohort data highlight key clinical subtypes - fixed myopathies, syndromic forms, and metabolic myopathies- with distinct diagnostic implications. Novel tools such as GDF-15, long-read mtDNA sequencing, and multi-omic approaches are enhancing diagnostic sensitivity. Emerging therapies for TK2 deficiency and precision mitochondrial gene editing are progressing rapidly, with several nearing regulatory decisions. Numerous preclinical therapeutic strategies are currently under development, offering promise for improving outcomes in these otherwise devastating disorders. Recognizing MM in clinical settings is essential for timely diagnosis, to guide prognosis and family planning as well as provide access to emerging treatment. A tiered diagnostic approach and integration of new genomic technologies can improve outcomes.
Human And Animal Rights:
This article does not contain any studies with human or animal subjects performed by any of the authors.
Insights
Mitochondrial myopathies (MM) are underrecognized genetic disorders. This review offers diagnostic and management guidance, highlighting new tools and therapies for improved patient outcomes.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Biology
Background:
- Mitochondrial myopathies (MM) represent a diverse group of genetic disorders.
- These conditions are often underdiagnosed in both pediatric and adult neurology settings.
Purpose of the Study:
- To provide a practical clinical guide for diagnosing and managing mitochondrial myopathies.
- To review advancements in diagnostic technologies and disease-modifying treatments for MM.
Main Methods:
- Review of large cohort data to identify key clinical subtypes.
- Analysis of novel diagnostic tools including GDF-15 and advanced sequencing.
- Evaluation of emerging therapeutic strategies and preclinical developments.
Main Results:
- Key MM subtypes (fixed, syndromic, metabolic) have distinct diagnostic implications.
- New tools like GDF-15 and long-read mtDNA sequencing improve diagnostic accuracy.
- Promising therapies for TK2 deficiency and gene editing are advancing rapidly.
Conclusions:
- Early recognition of MM is crucial for timely diagnosis, prognosis, and family planning.
- A tiered diagnostic approach integrating genomic technologies enhances patient outcomes.
- Emerging treatments offer hope for patients with these severe disorders.
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Mitochondrial Membranes
ATP Synthase: Mechanism
Mitochondria
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...


